Rethinking Leahy’s Emotional Schema Scale (LESS): Results from the Portuguese Adaptation of the LESS

This study aims to contribute to the study of emotional schemas, through the adaptation of the Leahy Emotional Schema Scale (LESS) to Portuguese. The LESS is a 50 item self-report with 14 theoretical dimensions, representing concepts, evaluations, attributions of emotions, and strategies of emotion regulation (Leahy in Cognit Behav Pract 9(3):177–190, 2002. https://doi.org/10.1016/S1077-7229(02)80048- 7). Translation, back-translation and pilot assessment of LESS’s Portuguese version were completed. Data was collected online with 396 participants. An exploratory principal component analysis was conducted. Parallel analysis revealed a 5-component structure, which after the deletion of eight items generated a fnal solution explaining 48% of the variance. Components internal consistency was adequate and convergent validity supported with signifcant correlations with difculties in emotional regulation and emotional processing, and psychopathology. It presents dimensions that are highly relevant for assessment, case conceptualization and clinical decision making. Although this scale is related to a specifc cognitive theory, the construct and its subscales may be useful beyond the psychotherapeutic model, stressing the transtheoretical potential of the scale.info:eu-repo/semantics/publishedVersio

Novel trivalent europium β-diketonate complexes with N-(pyridine-2-yl)amides and N-(pyrimidine-2-yl)amides as ancillary ligands: photophysical properties and theoretical structural modeling

Eighteen new Eu3+ complexes and their Gd3+ analogues with 1,3-diketonate as main ligands and N-(pyridine-2-yl)amides or N-(pyrimidine-2-yl)amides as ancillary ligands were synthesized. The replacement of water molecules by those amides in the Eu3+ complexes increase the intrinsic quantum yields of luminescence, making them comparable or even more efficient than Eu3+ complexes with standard ancillary ligands such as 2,2′-bipyridine. The luminescence spectra of Gd3+ complexes in comparison with the Eu3+ ones show that efficient ligand-to-metal intramolecular energy transfer processes take place. In most cases the experimental Judd-Ofelt intensity parameters (Ω2 and Ω4) for the Eu3+ complexes show variations as a function of the temperature (77 and 300 K) that overall apparently does not follow clearly any trend. For this reason, geometric variations (on the azimuthal angle φ and ancillary ligands distances) were carried out in the coordination polyhedron for simulating thermally induced structural changes. It has been observed that, in this way, the Ω2 and Ω4 can be satisfactorily reproduced by in silico experiments. It was concluded that, at low-temperature, the ancillary ligands become closer to the Eu3+ ion and the angular variations affect more Ω2 than Ω4, in agreement to the theoretical calculations. The use of N-(pyridine-2-yl)amides or N-(pyrimidine-2-yl)amides as ancillary ligands in Eu3+ 1,3-diketonates looks to be a good strategy for obtaining highly luminescent complexes.publishe

Portuguese recommendations for the use of biological and targeted synthetic diseasemodifying antirheumatic drugs in patients with rheumatoid arthritis – 2020 update

Objective: To update the recommendations for the treatment of rheumatoid arthritis (RA) with biological and targeted synthetic disease-modifying antirheumatic drugs (bDMARDs and tsDMARDs), endorsed by the Portuguese Society of Rheumatology (SPR). Methods: These treatment recommendations were formulated by Portuguese rheumatologists taking into account previous recommendations, new literature evidence and consensus opinion. At a national meeting, in a virtual format, three of the ten previous recommendations were re-addressed and discussed after a more focused literature review. A first draft of the updated recommendations was elaborated by a team of SPR rheumatologists from the SPR rheumatoid arthritis study group, GEAR. The resulting document circulated among all SPR rheumatologists for discussion and input. The level of agreement with each of all the recommendations was anonymously voted online by all SPR rheumatologists. Results: These recommendations cover general aspects such as shared decision, treatment objectives, systematic assessment of disease activity and burden and its registry in Reuma.pt. Consensus was also achieved regarding specific aspects such as initiation of bDMARDs and tsDMARDs, assessment of treatment response, switching and definition of persistent remission. Conclusion: These recommendations may be used for guidance of treatment with bDMARDs and tsDMARDs in patients with RA. As more evidence becomes available and more therapies are licensed, these recommendations will be updated.info:eu-repo/semantics/publishedVersio

The Portuguese Society of Rheumatology position paper on the use of biosimilars

Biotechnological drugs have become a fundamental resource for the treatment of rheumatic patients. Patent expiry of some of these drugs created the opportunity for biopharmaceutical manufacturers to develop biosimilar drugs intended to be as efficacious as the originator product but with a lower cost to healthcare systems. Due to the complex manufacturing process and highly intricate structure of biologicals, a biosimilar can never be an exact copy of its reference product. Consequently, regulatory authorities issued strict preclinical and clinical guidelines to ensure safety and efficacy equivalence and, in September 2013, the biosimilar of infliximab was the first biosimilar monoclonal antibody to be authorized for use in the European Union. The current document is a position statement of the "Sociedade Portuguesa de Reumatologia" (Portuguese Society of Rheumatology) on the use of biosimilar drugs in rheumatic diseases. Two systematic literature reviews were performed, one concerning clinical trials and the other one concerning international position papers on biosimilars. The results were presented and discussed in a national meeting and a final position document was discussed, written and approved by Portuguese rheumatologists. Briefly, this position statement is contrary to automatic substitution of the originator by the biosimilar, defends either a different INN or the prescription by brand name, supports that switching between biosimilars and the originator molecule should be done after at least 6 months of treatment and based on the attending physician decision and after adequate patient information, recommends the registration of all biosimilar treated patients in Reuma.pt for efficacy, safety and immunogenicity surveillance, following the strategy already ongoing for originators, and opposes to extrapolation of indications approved to the originator to completely different diseases and/or age groups without adequate pre-clinical, safety or efficacy data.info:eu-repo/semantics/publishedVersio

Bacterial cellulose production by Gluconacetobacter xylinus by employing alternative culture media

Bacterial cellulose (BC) is used in different fields as a biological material due to its unique properties. Despite there being many BC applications, there still remain many problems associated with bioprocess technology, such as increasing productivity and decreasing production cost. New technologies that use waste from the food industry as raw materials for culture media promote economic advantages because they reduce environmental pollution and stimulate new research for science sustainability. For this reason, BC production requires optimized conditions to increase its application. The main objective of this study was to evaluate BC production by Gluconacetobacter xylinus using industry waste, namely, rotten fruits and milk whey, as culture media. Furthermore, the structure of BC produced at different conditions was also determined. The culture media employed in this study were composed of rotten fruit collected from the disposal of free markets, milk whey from a local industrial disposal, and their combination, and Hestrin and Schramm media was used as standard culture media. Although all culture media studied produced BC, the highest BC yield60 mg/mLwas achieved with the rotten fruit culture. Thus, the results showed that rotten fruit can be used for BC production. This culture media can be considered as a profitable alternative to generate high-value products. In addition, it combines environmental concern with sustainable processes that can promote also the reduction of production cost.The authors would like to acknowledge the Brazil National Council of Technological and Scientific Development (CNPq, FAPESP, and CAPES), the financial support from FAPESP 2009/14897-7, and Fundacao para a Ciencia e a Tecnologia (FCT)/Portugal through the project PTDC/EBB-EBI/112170/2009 for the financial support and scholarship. Special thanks to Talita Almeida Vicentin for technical support

Levantamento semidetalhado dos solos de áreas do Ministério da Agricultura no Distrito Federal.

O presente levantamento de solos foi executado nos meses de junho e julho de 1966, pela Equipe de Pedologia e Fertilidade do Solo, através do Convênio M.A. - CONTAP-U.S.A.I.D./ BRASIL - Projeto de Levantamento de Recursos Naturais (PRO - AG...512-15-120-249), tendo-se para os trabalhos de campo contado com a colaboração da Direção do Colégio Agrícola de Brasília. A principal finalidade do levantamento foi a identificação e estudo das várias unidades de solos existentes na área levantada, compreendendo sua distribuição geográfica e delimitação cartográfica das áreas por elas ocupadas, além do estudo de suas características morfológicas, físicas, químicas e mineralógicas. Os trabalhos de mapeamento foram realizados utilizando-se fotografias aéreas escala 1:25.000. Faz parte do presente trabalho um capítulo referente a interpretação de levantamento de solos, visando avaliar a aptidão agrícola desses, dentro de cinco sistemas de manejo.bitstream/item/212069/1/EPFS-BT-8-1967.pdf; bitstream/item/213811/1/Mapa-Levantamento-semidetalhado-dos-solos-de-areas-do-M.A.-no-Distrito-Federal-1966.pdfAcompanha 1 mapa, p&b. Escala 1:25.000. Convênio M.A.-CONTAP-USAID/BRASIL. Projeto de Levantamento de Recursos Naturais (PRO-AG 512-15-120-249)

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURO bservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

Aims: Given the advances in atrial fibrillation (AF) management and the availability of new European Society of Cardiology (ESC) guidelines, there is a need for the systematic collection of contemporary data regarding the management and treatment of AF in ESC member countries. Methods and results: We conducted a registry of consecutive in- and outpatients with AF presenting to cardiologists in nine participating ESC countries. All patients with an ECG-documented diagnosis of AF confirmed in the year prior to enrolment were eligible. We enroled a total of 3119 patients from February 2012 to March 2013, with full data on clinical subtype available for 3049 patients (40.4% female; mean age 68.8 years). Common comorbidities were hypertension, coronary disease, and heart failure. Lone AF was present in only 3.9% (122 patients). Asymptomatic AF was common, particularly among those with permanent AF. Amiodarone was the most common antiarrhythmic agent used (~20%), while beta-blockers and digoxin were the most used rate control drugs. Oral anticoagulants (OACs) were used in 80% overall, most often vitamin K antagonists (71.6%), with novel OACs being used in 8.4%. Other antithrombotics (mostly antiplatelet therapy, especially aspirin) were still used in one-third of the patients, and no antithrombotic treatment in only 4.8%. Oral anticoagulants were used in 56.4% of CHA 2DS2-VASc = 0, with 26.3% having no antithrombotic therapy. A high HAS-BLED score was not used to exclude OAC use, but there was a trend towards more aspirin use in the presence of a high HAS-BLED score. Conclusion: The EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry has provided systematic collection of contemporary data regarding the management and treatment of AF by cardiologists in ESC member countries. Oral anticoagulant use has increased, but novel OAC use was still low. Compliance with the treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal. © The Author 2013

NEOTROPICAL XENARTHRANS: a data set of occurrence of xenarthran species in the Neotropics

Xenarthrans – anteaters, sloths, and armadillos – have essential functions for ecosystem maintenance, such as insect control and nutrient cycling, playing key roles as ecosystem engineers. Because of habitat loss and fragmentation, hunting pressure, and conflicts with 24 domestic dogs, these species have been threatened locally, regionally, or even across their full distribution ranges. The Neotropics harbor 21 species of armadillos, ten anteaters, and six sloths. Our dataset includes the families Chlamyphoridae (13), Dasypodidae (7), Myrmecophagidae (3), Bradypodidae (4), and Megalonychidae (2). We have no occurrence data on Dasypus pilosus (Dasypodidae). Regarding Cyclopedidae, until recently, only one species was recognized, but new genetic studies have revealed that the group is represented by seven species. In this data-paper, we compiled a total of 42,528 records of 31 species, represented by occurrence and quantitative data, totaling 24,847 unique georeferenced records. The geographic range is from the south of the USA, Mexico, and Caribbean countries at the northern portion of the Neotropics, to its austral distribution in Argentina, Paraguay, Chile, and Uruguay. Regarding anteaters, Myrmecophaga tridactyla has the most records (n=5,941), and Cyclopes sp. has the fewest (n=240). The armadillo species with the most data is Dasypus novemcinctus (n=11,588), and the least recorded for Calyptophractus retusus (n=33). With regards to sloth species, Bradypus variegatus has the most records (n=962), and Bradypus pygmaeus has the fewest (n=12). Our main objective with Neotropical Xenarthrans is to make occurrence and quantitative data available to facilitate more ecological research, particularly if we integrate the xenarthran data with other datasets of Neotropical Series which will become available very soon (i.e. Neotropical Carnivores, Neotropical Invasive Mammals, and Neotropical Hunters and Dogs). Therefore, studies on trophic cascades, hunting pressure, habitat loss, fragmentation effects, species invasion, and climate change effects will be possible with the Neotropical Xenarthrans dataset